Abstract:IntroductionUveal melanoma (UM) is the most common primary intraocular malignant tumor in adults, and the main treatment for UM is currently surgery and plaque brachytherapy. UM is highly susceptible to metastasis, which eventually occurs in nearly half of all patients; once metastasis occurs, patients have a poor prognosis and the condition is difficult to treat. Therefore, the identification of new and effective UM biomarkers is vital for the application of therapeutic strategies. Immunogenic cell death (ICD) is a type of regulatory cell death that activates adaptive immune responses and generates long-term immunological memory. ICD can promote antitumor immunity, which may be a potential immunotherapeutic strategy for UM. MethodsThe data of UM from the Cancer Genome Atlas (TCGA) was used as a training set and the data from Gene Expression Omnibus (GEO) was used as a validation set. To determine the expression pattern of ICD-related genes in UM, survival analysis and difference analysis was conducted. The ICD-related risk signature was constructed by employing the least absolute shrinkage and selection operator (LASSO) Cox regression. Subsequently, immune profile and somatic mutation analysis were performed. In addition, cell experiments were performed to verify the role of immunogenic cell death-related genes in UM. ResultsIn this study, we analyzed the relationship between ICD-related gene expression and UM patient prognosis, somatic mutations, and the tumor immune microenvironment. Importantly, we constructed a 5-gene ICD-related risk signature and confirmed it as a novel prognostic biomarker in UM patients. We found that the high-risk group had more immune cell infiltration and a worse prognosis than the low-risk group. In cellular experiments, we confirmed the high expression of FOXP3 inMUM2B andOCM-1A cell lines and that knockdown of FOXP3 markedly inhibited the proliferation of UM tumor cells. DiscussionICD-related genes play a critical role in the tumor immune microenvironment. Our results may contribute to the development of effective immunotherapies.

Expression of Markers Associated with Epithelial—Mesenchymal Transition and Extracellular Matrix Degradation in Human Uveal Melanoma

Expression and significance of telomerase in uveal melanoma

The Prognostic Landscape of Adaptive Immune Resistance Signatures and Infiltrating Immune Cells in the Tumor Microenvironment of Uveal Melanoma.

MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma

Characterization of extracellular vesicles isolated from different liquid biopsies of uveal melanoma patients

[The role of CXC and CC chemokines in patients with uveal melanoma]

Uveal melanoma: molecular-genetic mechanisms of arising and the therapeutic approaches

Revealing the structural microenvironment of high metastatic risk uveal melanomas following decellularisation

Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma

Identifying biomarkers and novel therapeutic targets in uveal melanoma

Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression

[Uveal Melanoma: Molecular and Genetic Mechanisms of Development and Therapeutic Approaches]

Immunohistochemical Analysis of Transcription Factors and Markers of Epithelial–Mesenchymal Transition (EMT) in Human Tumors

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma

Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma

Molecular characterization of metastatic progression in patient derived xenograft models of malignant uveal melanoma

The roles of genetic mutation and cytokines/chemokines in immune response and their association with uveal melanoma patient outcome

Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not

The Analysis of Inflammation-Related Proteins in a Cargo of Exosomes Derived from the Serum of Uveal Melanoma Patients Reveals Potential Biomarkers of Disease Progression

Uveal Melanoma: Molecular and Genetic Mechanisms of Development and Therapeutic Approaches

The role of monoglyceride lipase gene in promoting proliferation, metastasis, and free fatty acid accumulation in uveal melanoma cells